Barclays PLC Trevena Inc Transaction History

Barclays PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.5 $5,210 - $13,025	-26,051 Reduced 98.12%	498 $0
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $70,499 - $108,327	-171,949 Reduced 86.63%	26,549 $14,000
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $75,050 - $169,850	131,667 Added 197.01%	198,498 $116,000
Q3 2021 Nov 09, 2021	BUY	$1.11 - $1.7 $74,182 - $113,612	66,831 New	66,831 $83,000
Q2 2021 Aug 13, 2021	SELL	$1.46 - $2.25 $17,972 - $27,697	-12,310 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.77 - $2.93 $21,788 - $36,068	12,310 New	12,310 $22,000
Q4 2019 Feb 10, 2020	SELL	$0.62 - $1.06 $20 - $34	-33 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $299,281 - $509,416	-318,385 Reduced 99.99%	33 $0
Q1 2019 May 15, 2019	BUY	$0.51 - $1.88 $153,994 - $567,666	301,950 Added 1833.56%	318,418 $497,000
Q4 2018 Feb 14, 2019	BUY	$0.39 - $3.47 $384 - $3,417	985 Added 6.36%	16,468 $7,000
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $131,328 - $212,582	-94,481 Reduced 85.92%	15,483 $33,000
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $128,367 - $199,682	89,144 Added 428.17%	109,964 $158,000
Q1 2018 May 15, 2018	BUY	$1.51 - $2.06 $3,768 - $5,141	2,496 Added 13.62%	20,820 $34,000
Q4 2017 Feb 14, 2018	BUY	$1.4 - $2.6 $2,581 - $4,794	1,844 Added 11.19%	18,324 $29,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $36,585 - $45,979	16,480	16,480 $42,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.